| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| SFZN.SW - | BUY | 15,730 @ CHF 104.44 | CHF 1,642,841 | The ETF bought 15730 new shares of SFZN.SW (). The shares were bought for an average price of 104.44 compared to the previous average buy price of 107.217. This is -2.6% lower than average price of previous purchases of SFZN.SW. |
| BANB.SW - | HOLD | 0 @ CHF 53.1789 | CHF 0 | The current share valuation price of BANB.SW based on adjusted close was CHF 53.1789. The average price that BANB.SW shares were previous bought at was CHF 54.3418. The current market price is -2.1% lower than average price they were purchased at. The value of the holding in BANB.SW has increased by CHF 1,208 (USD $1,466) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 50.15 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 50.15. The average price that REC.MI shares were previous bought at was EUR 53.243. The current market price is -5.8% lower than average price they were purchased at. The value of the holding in REC.MI has increased by EUR 48,936 (USD $55,710) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 116.3 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 116.3. The average price that BIM.PA shares were previous bought at was EUR 112.653. The current market price is 3.2% higher than average price they were purchased at. The value of the holding in BIM.PA has increased by EUR 7,721 (USD $8,790) compared to the previous valuation of BioMerieux however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| GALD.SW - | HOLD | 0 @ CHF 100.55 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 100.55. The average price that GALD.SW shares were previous bought at was CHF 106.599. The current market price is -5.7% lower than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 40,851 (USD $49,576) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 54.1 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 54.1. The average price that ORNBV.HE shares were previous bought at was EUR 51.589. The current market price is 4.9% higher than average price they were purchased at. The value of the holding in ORNBV.HE has fallen by EUR 8,657 (USD $9,855) compared to the previous valuation of Orion Oyj |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 99.95 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 99.95. The average price that IPN.PA shares were previous bought at was EUR 108.128. The current market price is -7.6% lower than average price they were purchased at. The value of the holding in IPN.PA has increased by EUR 9,448 (USD $10,756) compared to the previous valuation of Ipsen SA however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 23.0657 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 23.0657. The average price that HIK.L shares were previous bought at was GBP 24.2327. The current market price is -4.8% lower than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 17,419 (USD $23,345) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 8.36 | EUR 0 | |
| DEMANT.CO - | HOLD | 0 @ DKK 31.5405 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 31.5405. The average price that DEMANT.CO shares were previous bought at was DKK 32.1673. The current market price is -1.9% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 2,126 (USD $324) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| AMP.MI - Amplifon SpA | HOLD | 0 @ EUR 16.79 | EUR 0 | The current share valuation price of AMP.MI based on adjusted close was EUR 16.79. The average price that AMP.MI shares were previous bought at was EUR 20.7139. The current market price is -18.9% lower than average price they were purchased at. The value of the holding in AMP.MI has fallen by EUR 1,038 (USD $1,182) compared to the previous valuation of Amplifon SpA |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ EUR 121.2 | EUR 0 | The current share valuation price of TUB.BR based on adjusted close was EUR 121.2. The average price that TUB.BR shares were previous bought at was EUR 133.283. The current market price is -9.1% lower than average price they were purchased at. The value of the holding in TUB.BR has increased by EUR 21,825 (USD $24,846) compared to the previous valuation of Financiere de Tubize SA however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| TECN.SW - | HOLD | 0 @ CHF 165.505 | CHF 0 | The current share valuation price of TECN.SW based on adjusted close was CHF 165.505. The average price that TECN.SW shares were previous bought at was CHF 192.309. The current market price is -13.9% lower than average price they were purchased at. The value of the holding in TECN.SW has increased by CHF 9,505 (USD $11,535) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ EUR 99.34 | EUR 0 | The current share valuation price of DIA.MI based on adjusted close was EUR 99.34. The average price that DIA.MI shares were previous bought at was EUR 97.3821. The current market price is 2.0% higher than average price they were purchased at. The value of the holding in DIA.MI has increased by EUR 6,392 (USD $7,277) compared to the previous valuation of DiaSorin SpA however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 205 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 205. The average price that DIM.PA shares were previous bought at was EUR 186.847. The current market price is 9.7% higher than average price they were purchased at. The value of the holding in DIM.PA has increased by EUR 48,435 (USD $55,140) compared to the previous valuation of Sartorius Stedim Biotech however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| GXI.DE - Gerresheimer AG | HOLD | 0 @ EUR 57.5 | EUR 0 | The current share valuation price of GXI.DE based on adjusted close was EUR 57.5. The average price that GXI.DE shares were previous bought at was EUR 68.7246. The current market price is -16.3% lower than average price they were purchased at. EUR 0 (USD $0) compared to the previous valuation of Gerresheimer AG however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| BAVA.CO - | HOLD | 0 @ DKK 20.7277 | DKK 0 | The current share valuation price of BAVA.CO based on adjusted close was DKK 20.7277. The average price that BAVA.CO shares were previous bought at was DKK 20.6449. The current market price is 0.4% higher than average price they were purchased at. The value of the holding in BAVA.CO has increased by DKK 7,135 (USD $1,088) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| AFX.DE - Carl Zeiss Meditec AG | HOLD | 0 @ EUR 59.5 | EUR 0 | The current share valuation price of AFX.DE based on adjusted close was EUR 59.5. The average price that AFX.DE shares were previous bought at was EUR 51.2. The current market price is 16.2% higher than average price they were purchased at. The value of the holding in AFX.DE has increased by EUR 7,293 (USD $8,303) compared to the previous valuation of Carl Zeiss Meditec AG however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 56.8573 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 56.8573. The average price that NOVO-B.CO shares were previous bought at was DKK 67.492. The current market price is -15.8% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has increased by DKK 1,717,479 (USD $261,941) compared to the previous valuation of Novo Nordisk A/S however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| NSIS-B.CO - | HOLD | 0 @ DKK 55.9127 | DKK 0 | The current share valuation price of NSIS-B.CO based on adjusted close was DKK 55.9127. The average price that NSIS-B.CO shares were previous bought at was DKK 53.0372. The current market price is 5.4% higher than average price they were purchased at. The value of the holding in NSIS-B.CO has increased by DKK 118,271 (USD $18,038) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| COLO-B.CO - | HOLD | 0 @ DKK 98.1319 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 98.1319. The average price that COLO-B.CO shares were previous bought at was DKK 98.9579. The current market price is -0.8% lower than average price they were purchased at. The value of the holding in COLO-B.CO has increased by DKK 25,663 (USD $3,914) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| SECT-B.ST - | HOLD | 0 @ SEK 26.3628 | SEK 0 | The current share valuation price of SECT-B.ST based on adjusted close was SEK 26.3628. The average price that SECT-B.ST shares were previous bought at was SEK 21.7917. The current market price is 21.0% higher than average price they were purchased at. The value of the holding in SECT-B.ST has increased by SEK 22,508 (USD $2,338) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| GETI-B.ST - | HOLD | 0 @ SEK 16.8687 | SEK 0 | The current share valuation price of GETI-B.ST based on adjusted close was SEK 16.8687. The average price that GETI-B.ST shares were previous bought at was SEK 18.4135. The current market price is -8.4% lower than average price they were purchased at. The value of the holding in GETI-B.ST has increased by SEK 96 (USD $10) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| ALK-B.CO - | HOLD | 0 @ DKK 19.6961 | DKK 0 | The current share valuation price of ALK-B.CO based on adjusted close was DKK 19.6961. The average price that ALK-B.CO shares were previous bought at was DKK 19.5516. The current market price is 0.7% higher than average price they were purchased at. The value of the holding in ALK-B.CO has increased by DKK 12,897 (USD $1,967) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| AMBU-B.CO - | HOLD | 0 @ DKK 15.6497 | DKK 0 | The current share valuation price of AMBU-B.CO based on adjusted close was DKK 15.6497. The average price that AMBU-B.CO shares were previous bought at was DKK 16.2983. The current market price is -4.0% lower than average price they were purchased at. The value of the holding in AMBU-B.CO has increased by DKK 2,155 (USD $329) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| EKTA-B.ST - | HOLD | 0 @ SEK 4.45762 | SEK 0 | The current share valuation price of EKTA-B.ST based on adjusted close was SEK 4.45762. The average price that EKTA-B.ST shares were previous bought at was SEK 5.05196. The current market price is -11.8% lower than average price they were purchased at. The value of the holding in EKTA-B.ST has fallen by SEK 19,042 (USD $1,978) compared to the previous valuation of |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 37.33 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 37.33. The average price that QIA.DE shares were previous bought at was EUR 42.7392. The current market price is -12.7% lower than average price they were purchased at. The value of the holding in QIA.DE has increased by EUR 19,880 (USD $22,632) compared to the previous valuation of QIAGEN NV however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| SDZ.SW - | HOLD | 0 @ CHF 39.0902 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 39.0902. The average price that SDZ.SW shares were previous bought at was CHF 40.3859. The current market price is -3.2% lower than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 120,326 (USD $146,027) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 286.569 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 286.569. The average price that ROG.SW shares were previous bought at was CHF 288.84. The current market price is -0.8% lower than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 1,208,864 (USD $1,467,068) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 124.891 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 124.891. The average price that AZN.L shares were previous bought at was GBP 130.456. The current market price is -4.3% lower than average price they were purchased at. The value of the holding in AZN.L has increased by GBP 624,951 (USD $837,579) compared to the previous valuation of AstraZeneca PLC however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 94.23 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 94.23. The average price that SAN.PA shares were previous bought at was EUR 101.196. The current market price is -6.9% lower than average price they were purchased at. The value of the holding in SAN.PA has increased by EUR 527,161 (USD $600,138) compared to the previous valuation of Sanofi SA however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 16.8435 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 16.8435. The average price that GSK.L shares were previous bought at was GBP 16.412. The current market price is 2.6% higher than average price they were purchased at. The value of the holding in GSK.L has increased by GBP 448,230 (USD $600,732) compared to the previous valuation of GlaxoSmithKline PLC however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 250.4 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 250.4. The average price that EL.PA shares were previous bought at was EUR 260.835. The current market price is -4.0% lower than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 36,931 (USD $42,043) compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 625.358 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 625.358. The average price that LONN.SW shares were previous bought at was CHF 588.16. The current market price is 6.3% higher than average price they were purchased at. The value of the holding in LONN.SW has increased by CHF 207,288 (USD $251,563) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| ALC.SW - | HOLD | 0 @ CHF 84.5108 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 84.5108. The average price that ALC.SW shares were previous bought at was CHF 82.3493. The current market price is 2.6% higher than average price they were purchased at. The value of the holding in ALC.SW has increased by CHF 139,313 (USD $169,069) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 552.6 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 552.6. The average price that ARGX.BR shares were previous bought at was EUR 562.164. The current market price is -1.7% lower than average price they were purchased at. The value of the holding in ARGX.BR has increased by EUR 284,793 (USD $324,218) compared to the previous valuation of Argenx SE however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.43905 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.43905. The average price that HLN.L shares were previous bought at was GBP 4.61467. The current market price is -3.8% lower than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 23,406 (USD $31,369) compared to the previous valuation of Haleon PLC however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 155.9 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 155.9. The average price that UCB.BR shares were previous bought at was EUR 165.159. The current market price is -5.6% lower than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 315,226 (USD $358,864) compared to the previous valuation of UCB SA however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 23.17 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 23.17. The average price that BAYN.DE shares were previous bought at was EUR 20.6024. The current market price is 12.5% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 74,145 (USD $84,409) compared to the previous valuation of Bayer AG however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 121.95 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 121.95. The average price that MRK.DE shares were previous bought at was EUR 125.212. The current market price is -2.6% lower than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 38,504 (USD $43,834) compared to the previous valuation of Merck KGaA |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 22.02 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 22.02. The average price that PHIA.AS shares were previous bought at was EUR 23.8839. The current market price is -7.8% lower than average price they were purchased at. The value of the holding in PHIA.AS has fallen by EUR 61,665 (USD $70,201) compared to the previous valuation of Koninklijke Philips NV |
| NOVN.SW - | HOLD | 0 @ CHF 100.401 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 100.401. The average price that NOVN.SW shares were previous bought at was CHF 98.3879. The current market price is 2.0% higher than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 753,608 (USD $914,573) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 266.321 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 266.321. The average price that SOON.SW shares were previous bought at was CHF 285.779. The current market price is -6.8% lower than average price they were purchased at. The value of the holding in SOON.SW has fallen by CHF 19,779 (USD $24,004) compared to the previous valuation of |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 46.86 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 46.86. The average price that SHL.DE shares were previous bought at was EUR 51.5254. The current market price is -9.1% lower than average price they were purchased at. The value of the holding in SHL.DE has fallen by EUR 43,535 (USD $49,562) compared to the previous valuation of Siemens Healthineers AG |
| GMAB.CO - | HOLD | 0 @ DKK 184.165 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 184.165. The average price that GMAB.CO shares were previous bought at was DKK 172.977. The current market price is 6.5% higher than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 87,283 (USD $13,312) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| STMN.SW - | HOLD | 0 @ CHF 108.862 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 108.862. The average price that STMN.SW shares were previous bought at was CHF 114.879. The current market price is -5.2% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 37,419 (USD $45,411) compared to the previous valuation of |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 40.94 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 40.94. The average price that FRE.DE shares were previous bought at was EUR 37.485. The current market price is 9.2% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 49,023 (USD $55,809) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 11.7151 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 11.7151. The average price that SN.L shares were previous bought at was GBP 11.9511. The current market price is -2.0% lower than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 10,422 (USD $13,968) compared to the previous valuation of Smith & Nephew PLC |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 43.74 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 43.74. The average price that FME.DE shares were previous bought at was EUR 44.555. The current market price is -1.8% lower than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 10,259 (USD $11,679) compared to the previous valuation of Fresenius Medical Care AG |
| ZEAL.CO - | HOLD | 0 @ DKK 60.7094 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 60.7094. The average price that ZEAL.CO shares were previous bought at was DKK 78.5672. The current market price is -22.7% lower than average price they were purchased at. The value of the holding in ZEAL.CO has increased by DKK 69,548 (USD $10,607) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| SOBI.ST - | HOLD | 0 @ SEK 26.6363 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 26.6363. The average price that SOBI.ST shares were previous bought at was SEK 26.0522. The current market price is 2.2% higher than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 104,507 (USD $10,855) compared to the previous valuation of however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 54.1 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 54.1. The average price that ERF.PA shares were previous bought at was EUR 48.9037. The current market price is 10.6% higher than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 24,690 (USD $28,108) compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 228 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 228. The average price that SRT3.DE shares were previous bought at was EUR 219.465. The current market price is 3.9% higher than average price they were purchased at. The value of the holding in SRT3.DE has increased by EUR 39,008 (USD $44,408) compared to the previous valuation of Sartorius AG however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |
| CTEC.L - ConvaTec Group PLC | HOLD | 0 @ GBP 3.037 | GBP 0 | The current share valuation price of CTEC.L based on adjusted close was GBP 3.037. The average price that CTEC.L shares were previous bought at was GBP 2.87216. The current market price is 5.7% higher than average price they were purchased at. The value of the holding in CTEC.L has increased by GBP 16,031 (USD $21,485) compared to the previous valuation of ConvaTec Group PLC however if the holding was sold on 2025-04-29 this would crystalise an overall loss. |